InvestorsHub Logo
Followers 15
Posts 1029
Boards Moderated 0
Alias Born 09/17/2015

Re: None

Thursday, 10/22/2015 10:48:46 PM

Thursday, October 22, 2015 10:48:46 PM

Post# of 6649
VBTL announced positive results from its multi-cohort Phase 2 trial of VB-111 in advanced radioiodine-refractory differentiated thyroid cancer (RAIR-DTC).

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.